1. AF ablation in the East - Is it under prescribed?

Shinsuke Miyazaki

Japan

2. Should all AF <1 year offered an ablation?

Oussama Wazni

United States

3. AF ablation - Where should we draw the line?

Ting-Yung Chang

Taiwan

4. AF ablation - When resources are limit who has priority?

Joseph YS Chan

Hong Kong SAR

5. Persistent AF ablation outcome: How to improve?

Aman Chugh

United States

1. Clinical utility of innovative mapping-guided ablation 

Ryan Aleong

United States

2. AF ablation: PVI alone or PVI plus?

Minglong Chen

China

3. Redos AF ablation: The next frontier

Andrea Natale

United States

4. AF ablation of the right atrium

Jaemin Shim

Korea

5. AF ablation: When goes to the epicardium?

Li-Wei Lo

Taiwan

1. Biophysics

Damijan Miklavčič

Slovenia

2. Contact and contact force - Is it relevant in lesion formation

Atul Verma

United States

3. To treat paroxysmal AF

Tom Wong

United Kingdom

4. PVI plus - Are we there yet?

Boris Schmidt

Germany

5. Complications

Edward Gerstenfeld

United States

1. Cryoballoon: Should we offer this to all denovo AF ablation?

Tianyou Ling

China

2. Balloon catheters - Is heat better?

Feifan Ouyang
Zulu Wang

Germany
(China)

3. High power short duration - The optimal power setting

Seil Oh

Korea

4. Novel technologies - What is round the corner

Oussama Wazni

United States

5. Debate:
    PFA will replace all other energy source in ablating AF

Protagonist:
Atul Verma
Antagonist:
Tom Wong

United States

United Kingdom

1. AFCA & LV function: HFrEF & HFpEF

Seiji Takatsuki

Japan

2. AF with genetic background

Hui-Nam Pak

Korea

3. Role of epicardium in AF maintenance mechanism

Young-Hoon Kim

Korea

4. Epicardial adipose tissue and AF

Ling Kuo

Taiwan

5. Debate:
    AF with SA nodal dysfunction: AF ablation should be performed first even pacemaker is necessary

Protagonist:
Meleze Hocini
Antagonist:
David Benditt

France

United States

1. Cardio-concology: AF ablation in patients with cancer

Matthew O'Connor

New Zealand

2. Is AF in heart failure ablatable?

Jiun Haur Tuan

Malaysia

3. AF ablation in congenital heart disease

David Bradley

United States

4. AF in pulmonary hypertension - A right or left atrial disease?

David Spragg

United States

1. PV isolation: How to assess its quality?

Yigang Li

China

2. Non-PV trigger ablation

Yung-Kuo Lin

Taiwan

3. Substrate modification beyond PV isolation

Masateru Takigawa

Japan

4. GP ablation: Who and When?

Sunny Po

United States

5. Debate:
    Marshall vein ablation as a matter of routine for all persistent AF ablation

Protagonist:
Meleze Hocini
Antagonist:
Andrea Natale

France

United States

1. What did we learn from EAST-AFNET4 substudies?

Shaowen Liu

China

2. AF and Life-style: Obesity, OSA, Alcohol, & Coffee

Prashanthan Sanders

Australia

3. Sex and Age differences

Teiichi Yamane

Japan

4. Future perspectives in AFCA

Young-Hoon Kim

Korea

1. What is the ‘Clinically Complex’ AF patient

Wee-Siong Teo

Singapore

2. A holistic or integrated care approach: Easy as ABC

Mingfang Li

China

3. Multimorbidity, frailty and AF-related risks

Prashanthan Sanders
Varun Malik

Australia
Australia

4. Rate or rhythm control? 

Eue-Keun Choi

Korea

1. Impact of rhythm control on stroke

Boyoung Joung

Korea

2. Oral anticoagulation: Asian versus Western differences

Agung Fabian Chandranegara

Indonesia

3. Epidemiology and the potential of screening

Yutao Guo
Gregory Y Lip

China
United Kingdom

4. Prevention of atrial fibrillation and stroke by lifestyle modifications

Takashi Kurita

Japan

1. CHA2DS2-VASc or CHA2DS2-VA for stroke risk?

Gregory Y Lip

United Kingdom

2. Stroke and bleeding risk stratification in atrial fibrillation: Where are we now?

Rungroj Krittayaphong

Thailand

3. The use and abuse of bleeding risk scores: HASBLED, ORBIT, ATRIA and more

Tatjana Potpara
Gregory Y Lip

Serbia
United Kingdom

4. Do we anticoagulate patients with a single non-sex stroke risk factor?

Yong Seog Oh

Korea

1. Finding AF: Looking harder, looking longer and looking in more sophisticated ways

Yoga Yuniadi

Indonesia

2. New insights into mHealth or sensors: The rise of the machines?

Yutao Guo

China

3. Prevention of ischemic stroke and dementia in people with atrial myopathy

Lin Yee Chen

United States

Ardian Rizal

Indonesia

Why do we need a holistic or integrated care approach to AF? 

Lin Yee Chen

United States

A: Avoid stroke with Anticoagulation

Mohd Ridzuan Mohd Said

Malaysia

B: Patient-centred symptom directed rhythm or rate control

Giselle Gervacio

Philippines

C: Comorbidities and lifestyle management

So-Ryoung Lee

Korea

Debate:
Topic 1: We should use more left atrial appendage occlusion for more patients

(Pro) Yat-Yin Lam

Hong Kong SAR

(Contra) Gregory Y Lip

United Kingdom

Debate:
Topic 2: Early rhythm control is for everyone to reduce mortality and stroke risk

(Pro) Josef Kautzner

Czech Republic

(Contra) Tatjana Potpara

Serbia

1. What are the prerequisites for VT ablation: Understanding ventricular anatomy, clinical VT characterization

David Spragg

United States

2. Should MR imaging be mandatory prior to ablative intervention: What can we learn from MR integrated substrate mapping?

Thorsten Lewalter

Germany

3. My approach to ischemic and non-ischemic ventricular mapping

Luigi di Biase
Andrea Natale

United States
United States

4. The optimal time for catheter ablation of ventricular tachycardia: Early or after ICD implant?

Kalyanam Shivkumar

United States

1. Epicardial ablation for ventricular tachycardia: Avoiding the pitfalls of related complications

Akihiko Nogami

Japan

2. Catheter ablation in Brugada syndrome

Koonlawee Nademanee

United States

3. Role of intracardiac ultrasound in guided VT ablation: From PVC's to ICE-guided structural interventions

Josef Kautzner

Czech Republic

4. What is the effect of LAVA, border-zone homogenization and substrate ablation for ventricular tachycardia?

Luigi di Biase
Andrea Natale

United States
United States

5. The utility of needle tip, saline heating and extracoporeal ablation for elimination of ventricular tachycardia

Douglas Packer

United States

1. PVC-induced cardiomyopathy

Venkat N. Tholakanahalli

United States

2. Cardiac anatomy for outflow tract ablation

Ignatius Yansen

Indonesia

3. Ablation for papillary muscle VT/PVC

Yae Min Park

Korea

4. Current understanding and ablation approach for fascicular ventricular tachycardia

Akihiko Nogami

Japan

5. Predictors of successful endocardial ablation of epicardial LV summit arrhythmias

Takumi Yamada

United States

1. VT ablation in ARVC patients: Substrate isolation

Minglong Chen

China

2. Summary of EGM-based substrate ablation for VT

Henry Hsia

United States

3. Decrement Evoked Potential (DEEP) mapping for VT substrate ablation

Deepak Padmanabhan

India

4. Substrate mapping for scar-related VT

Nitish Badhwar

United States

1. Intraoperative epicardial VT ablation at the time of LVAD implant

Li-Ting Ho

Taiwan

2. Surgical sympathectomy

Kalyanam Shivkumar

United States

3. Intractable VT/VF in OHCA with ROSC

Jiunn-Lee Lin

Taiwan

4. Substrate mapping for repeat ablation procedures

Rahul Singhal

India

1. Diagnosis of SVT Mechanism using 12-lead EKG

Phan Dinh Phong

Vietnam

2. Baseline observations and evidence of substrate in the EP lab before SVT induction

Kartikeya Bhargava

India

3. SVT features in the EP lab that help to make the diagnosis

Kwok-Keung Chan

Hong Kong SAR

4. Atrial pacing maneuvers to differentiate SVT

Il-Young Oh

Korea

5. Ventricular pacing maneuvers to differentiate SVTs

Bradley P. Knight

United States

1. Use of focal cryoablation for SVT ablations

Ngai-Yin Chan

Hong Kong SAR

2. Using 3D mapping systems during SVT ablation

Brian Williamson

United States

3. Use of Intracardiac Echocardiography (ICE) during SVT ablation

Josef Kautzner

Czech Republic

4. SVT ablation without the use of fluoroscopy

Chih-Chieh Yu

Taiwan

5. Transeptal catheterization techniques for SVT ablation

Bradley P. Knight

United States

1. How to ablate typical AVNRT 

Lawrance Jesuraj Masilamani

India

2. How to ablate focal atrial tachycardias

Jonathan Kalman

Australia

3. How to ablate manifest accessory pathways

Jo Jo SH Hai

Hong Kong SAR

4. How to ablate concealed accessory pathways 

Saruul Tseveendee

Mongolia

5. How to ablate atypical AVNRT

Zulu Wang

China

1. Ablation of AVRT/accessory pathways: Difficult cases 

Raymond Sy

Australia

2. Ablation of Focal Atrial Tachycardia

Nwe Nwe

Myanmar

3. Ablation of paraHisian ATs and APs

Bradley P. Knight

United States

4. Ablation of SVTs within the coronary veins 

Narayanan Namboodiri

India

1. Pacing-induced cardiomyopathy: How much pacing can the heart take?

Hung-Fat Tse

Hong Kong SAR

2. Pacing for syncope prevention, does it work?

David Benditt

United States

3. Dealing with CIED infections in the Elderly

Nigel Lever

New Zealand

4. AV-synchronous or ventricular back-up pacing for intermittent AV block?

Yuji Nakazato

Japan

5. Conduction block after TAVR /cardiac surgery - Wait and see or immediate PM?

Bobby John

Australia

1. What are the benefits of remote care for PM

Jong-Il Choi

Korea

2. Remote Care - Indication and Guidelines

Pipin Kojodjojo

Singapore

3. Optimal PM programming - What is new in 2023?

Jhi Hui Foo

Malaysia

4. PM induced tricuspid valve dysfunction: Achilles heel of leads?

Kai-Hang Yiu

Hong Kong SAR

1. Safety of TVPM versus LCP

Dong-Hyeok Kim

Korea

2. VVI vs VVI-R LCP: How does it work

Chu-Pak Lau

Hong Kong SAR

3. Optimal implant technique of LCP

Chin-Pang Chan

Hong Kong SAR

4. DDDR dual device LCPM

Reinoud Knops

Netherlands

5. LCP combined with S-ICD - Modular approach

Lucas Boersma

Netherlands

1. Induced pluripotent stem cells in the search of novel therapies for genetic arrhythmias

Luca Sala

Italy

2. Sudden cardiac death in young athletes: The case of ARVC

Yongkeun Cho

Korea

3. Long QT syndrome in Japan: Data from a nationwide registry

Takeshi Aiba

Japan

4. The role of left cardiac sympathetic denervation in channelopathies

Jien-Jiun Chen

Taiwan

1. Progress and problems in the management of CPVT

Andrew Davis

Australia

2. Progress and problems in the management of LQTS

Peter J Schwartz

Italy

3. Early repolarization in athletes

Brian Olshansky

United States

4. Appropriate and inappropriate use of radio frequency ablation in genetic arrhythmias

Koonlawee Nademanee

United States

5. Genetic testing and risk stratification in the Brugada syndrome

Wataru Shimizu

Japan

1. Global burden of sudden cardiac death in Asia

Wei Hua

China

2. New paradigm in prediction

Kumar Narayanan

India

3. Challenges and opportunities to improve outcomes in Asia

Kumar Narayanan

India

4. Genetics of sudden cardiac death

Jodie Ingles

Australia

1. Can artificial intelligence tools improve prevention of sudden cardiac death?

Sumeet Chugh

United States

2. The overlap with J wave syndromes and short-coupled PVC

Priya Chockalingam

India

3. Current management approaches and outcomes for the patient and their family

Martin Stiles

New Zealand

4. What do we understand from genetics and genomics?

Michael Ackerman

United States

1. ICD indications in non-ischaemic dilated cardiomyopathy

Jiangang Zou

China

2. ICD indications in hypertrophic cardiomyopathy

Kwok-Keung Chan

Hong Kong SAR

3. ICD indications in channelopathies

Priya Chockalingam

India

4. Which type of ICD should I implant in the young patient with inherited heart disease and how should I program it?

Elizabeth Sherwin

United States

1. Advances in cardiac monitoring for diagnosing Syncope/Collapse

Darshan Krishnappa

India

2. Syncope/Collapse: Recognition of channelopathies and their management

Ngai-Shing Mok

Hong Kong SAR

3. 'Rules of the road’: Understanding assessment of Syncope and sudden death risk among commercial drivers - Who should be disqualified?

Haruhiko Abe

Japan

4. Rare forms of Reflex or Reflex-like Syncope

David Benditt

United States

1. Is the Tilt-table test useful? - An ongoing debate

Brian Olshansky

United States

2. Are risk scores useful in evaluating causes of Syncope/Collapse?

Teerapat Nantsupawat

Thailand

3. Physical maneuvers to terminate Vasovagal Syncope and Prevent recurrences

Jayaprakash Shenthar

India

4. POTS: a Complex Syndrome needing multidisciplinary management

Dennis Lau

Australia

1. Anatomic and Physiologic Rationale for Cardioneuroablation in Reflex Syncope?

Sri Sundaram

United States

2. Ablation for sinus node dysfunction and functional AVB block

Jhi Hui Foo

Malaysia

3. Ablation for autonomic AF

Roin Rekvava

Georgia

1. Current indications update, shared decision-making and controversies (nonischemic cardiomyopathy, LVAD patients)

Jin-Long Huang

Taiwan

2. Optimal programming, minimising inappropriate shocks

Ikutaro Nakajima

Japan

3. Defibrillation and cardiac resynchronisation in children and congenital heart disease

Aya Miyazaki

Japan

4. Sport, Sudden cardiac death, Implantable defibrillators - Current best practice

Erik YM Fung

Hong Kong SAR

1. Disabling ICD therapy, practical guidance, and end-of-life considerations

Swee-Chong Seow

Singapore

2. The extra-vascular defibrillator

Ian Crozier

New Zealand

3. The future of defibrillation: Low energy and painless defibrillation

Venkat N. Tholakanahalli

United States

4. Computer modelling and identifying sudden cardiac death risk

Sumeet Chugh

United States

1. Latest advances in implantable defibrillators

Paul Wang
Ian Crozier

United States
New Zealand

2. Subcutaneous defibrillators - Current best practice implantation

Lucas Boersma

Netherlands

3. Subcutaneous defibrillators - Latest trial data, Praetorian trial

Reinoud Knops

Netherlands

4. Early detection of heart failure by ICD

Katherine YY Fan

Hong Kong SAR

Chairpersons:
Hiroko Asakai (Japan), Yoo-Ri Kim (Korea), Amit Kumar Malik (India)

1. CSP in paediatric patients - tips and tricks

Jayaprakash Shenthar

India

2. LBB pacing and CRT-P in paediatrics (Pros)

Chencheng Dai

China

3. LBB pacing and CRT-P in paediatrics (Cons)

Aya Miyazaki

Japan

4. Innovation of pacing in paediatrics and congenital heart disease

Elizabeth Sherwin

United States

Chairpersons:
Jemelee Hernandez-Albano (Philippines), Suguru Nishiuchi (Japan), Tak-Cheung Yung (Hong Kong SAR)

1. Innovation and gene therapy in cardiac channelopathy

Michael Ackerman

United States

2. Complex SCN5A syndrome that were difficult to treat

Yoko Yoshida

Japan

3. Sudden cardiac death during sports

Sumeet Chugh

United States

4.An Ablationalist approach to Channelopathies

Koonlawee Nademanee

United States

Chairpersons:
Dony Yugo Hermanto (Indonesia), Jie-Ying Lee (Singapore), Kin-Shing Lun (Hong Kong SAR)

1. Lead extraction in pediatrics

Douglas Mah

United States

2. Ablation of atriofascicular arrhythmias in Ebstein anomaly

Narayanan Namboodiri

India

3. Ventricular ectopy – What is the differential diagnosis in children

Apichai Khongphatthanayothin

Thailand

4. Retroflex ablation right sided WPW

Douglas Mah

United States

Chairpersons:
Ji-Eun Ban (Korea), Elaine Boey (Singapore), Chatyapha Sriprom (Thailand), Jun Yoshimoto (Japan)

1. Ablation in adult ccTGA

Elizabeth Sherwin

United States

2. Ablation in ACHD Fontan

Wee-Tiong Yeo

Singapore

3. Pacemaker programming in ACHD with atrial arrhythmias

Supaluck Kanjanuthai

Thailand

4. Ablation in mustards/atrial switch

David Bradley

United States

1. Current updates of hybrid ablation for persistent atrial fibrillation: Over 700 cases experiences

Dong-Seop Jeong

Korea

2. Recent of updates in LAA exclusion: From suture to clip

Daniel TL Chan

Hong Kong SAR

3. How to prepare for the pulsed field ablation era as an arrhythmia surgeon

Nitish Badhwar

United States

4. 2023 APHRS expert consensus statements on surgery for AF: Differences from the past

Takashi Nitta

Japan

1. Groundwork - Basics in Anatomy, EGM and Rhythm interpretation

Chun-Ja Yoo

Korea

2. Stimulation Concepts - Basics of stimulation protocols, Entrainment, Excitable gap

John Roshan Jacob

India

3. Electroanatomic Mapping - Technologies, Setup, How they work and troubleshooting

Brian Williamson

United States

4. Real-time signal analysis in cardiac electrophysiology: Applications in the EP lab

Anand Ganesan

Australia

1. Diagnostic maneuvers in differentiation of SVT

Raja Selvaraj

India

2. Stepwise approach to atrial flutter ablation

Shu-Fen Liang

Singapore

3. Tips and Tricks in PVI ablation

Luke Shanahan

Australia

4. Workflow enhancement for Paroxysmal AF ablation in the EP lab

Ivan Ho

United States

1. Mechanisms of wide complex tachycardias

Chang-Hee Lee

Korea

2. Challenging cases: From EP lab setup to catheter alation of VT - What can go wrong?

Hyun-Soo Lee

Korea

3. An introduction to various approaches and mapping strategies for ventricular arrythmia

Yuet-Wong Cheng

Hong Kong SAR

4. Interactive cases - Management of VT with Device vs Medication vs Ablation
Panelists:
Duy Linh Nguyen (Vietnam), Deep Chandh Raja (India)

Raja Selvaraj

India

1. Cases - Leadless Pacing: Follow up troubleshooting strategies

Mark TK Tam

Hong Kong SAR

2. Comparing PMT and minimal ventricular pacing algorithms across manufacturers

Frank LY Tam

Hong Kong SAR

3. Step-by-Step in LBB pacing: Techniques, Troubleshooting and Follow Up

Luke Shanahan

Australia

4. Interactive cases - Systematic approach to pacemaker follow up and tailored programming for patients
Panelists:
Hailei Liu (China), Van Dang Nguyen (Vietnam)

Marleen Irwin

Canada

1. Comparing ICD detection and discrimination algorithms across manufacturers

Fiona SM Yuen

Hong Kong SAR

2. Interactive cases - ICD EGM Interpretation
Panelist:
Kush Kumar Bhagat (India)

Edward Barin

Australia

3. ICD patient education – EMI, Sports, Psychosocial Considerations

Gareth Wynn

Australia

4. S-ICD: What you need to know

Tohru Ohe

Japan

1. Interactive cases: Troubleshooting ICD and CRT-D
Panelists:
Seksak Moonsarn (Thailand), Zefeng Wang (China)

Ho-Chuen Yuen

Hong Kong SAR

2. CRT Optimization: Device based algorithms vs Echo vs ECG - What works?

Marleen Irwin

Canada

3. Heart Failure, dyssynchrony in CRT-D: Concepts, indications and implant techniques

Daniel Chong

Singapore

4. How to reduce radiation exposure in EP lab

Jae-Sun Uhm

Korea

1. Using hiPSC-derived cardiomyocytes to assess drug safety

Luca Sala

Italy

2. Disrupted CaV1.2 selectivity causes overlapping long QT and Brugada syndrome phenotypes in iPS cell model

Takeru Makiyama

Japan

3. Circulating microRNAs as the biomarkers for arrhythmias

Rajesh Katare

New Zealand

4. Zebra fish model of long-QT syndrome

Kenshi Hayashi

Japan

5. Extracellular vesicles and arrhythmia - a Diagnostic biomarker and treatment

Boyoung Joung

Korea

1. Endothelial-to-mesenchymal transition in atrial fibrillation

Yung-Hsin Yeh

Taiwan

2. Tachypacing-induced CREB/CD44 signaling contributes to atrial remodeling

Yi-Hsin Chan

Taiwan

3. Inhibition of late sodium current via PI3K/Akt signaling prevents cellular remodeling in tachypacing-induced HL-1 atrial myocytes

Jong-Il Choi

Korea

4. Biological pacing by non-viral TBX18 gene transfer and TGF-b inhibition

Ki-Hong Lee

Korea

1. ILRs for AF monitoring, including use of AI for data management optimization

Suneet Mittal

United States

2. Machine learning for distinguishing right from left PVC origin

Fengxiang Zhang

China

3. Prognostication of post-ablation AF recurrence: Role of explainable artificial intelligence

Dae-In Lee

Korea

4. Artificial intelligence - Assisted ECG reading

Emmanuel CK Wong

Hong Kong SAR

1. Genetic Basis of Early Repolarization Syndrome

Dan Hu

China

2. Bayian penetrance estimates for variant interpretation

Seiko Ohno

Japan

3. Genetics and inherited arrhythmias

Susan Etheridge

United States

4. Genetic basis of sudden death after COVID-19 vaccination in Thailand

Vorasuk Shotelersuk

Thailand

1. Autonomic nervous system and atrial fibrillation

Peng-Sheng Chen

United States

2. Inflammatory mechanisms in postoperative atrial fibrillation

Xander Wehrens

United States

3. Effects of AF ablation on autonomic nerve activity

Jien-Jiun Chen

Taiwan

4. Enhanced Ca2+-dependent SK-channel gating and membrane trafficking in human atrial fibrillation

Dobromir Dobrev

Germany

1. EHRA conduction system pacing implantation clinical consensus statement - Top take-aways

Haran Burri

Switzerland

2. HRS/APHRS/LAHRS cardiac physiologic pacing guideline - Top take-aways

Mina Chung

United States

3. Clinical trials for CSP

Weijian Huang

China

4. Debate:
    All patients undergoing pacemaker implantation should receive CSP

Protagonist:
Hung-Pin Wu
Antagonist:
Sofian Johar

Taiwan

Brunei

Panel Discussion

5. Debate:
    CSP should replace CRT in a patient with EF<35%, LBBB and QRS duration 160 ms

Protangonist:
Pugazhendhi Vijayaraman
Antagonist:
Mina Chung

United States

United States

Panel Discussion

1. How to place a HB lead (with recorded case highlights)

Kuan-Cheng Chang

Taiwan

2. How to achieve a high success rate of LBB capture: Tips and tricks (with recorded case highlights) (4-lead body sfc ECG)

Lan Su

China

3. How to optimize LBBAP

Weijian Huang

China

4. Tools for CSP: Stylet or non-stylet driven approaches (with recorded case highlights) or stylet-driven LBBAP

Haran Burri

Switzerland

5. The feasibility and efficacy of left bundle area pacing In Paediatric patient (with recorded cases highlight)

Muhammad Yamin

Indonesia

6. New artificial intelligence and ECG techniques to predict response to CSP: Are these ready for prime time?

Deepak Padmanabhan

India

7. Best patient selection and techniques for patients with heart failure: CSP vs CRT

Joseph YS Chan

Hong Kong SAR

1. HBP and LBBAP - How to confirm HB capture and Purkinje recruitment

Kartikeya Bhargava

India

2. Differentiating LBBAP from LVSP

Jodie Hurwitz

United States

3. Overcoming difficulties in CSP lead placement (with recorded case highlights)

Pugazhendhi Vijayaraman

United States

4. Troubleshooting, programming, and follow-up of CSP

Sung-Hao Huang

Taiwan

5. Is HBP superior to LBBAP?

Chi-Keong Ching

Singapore

6. Panel Discussion

1. Conduction system pacing: Current indication and indication expansion for CRT

Weijian Huang

China

2. Approaches to achieve optimal electrical synchronization by LBBP

Pipin Kojodjojo

Singapore

3. How to achieve LBB capture safely and reliably: Tips and Tricks

Xueying Chen

China

4. The status and improvement of HBP in the era of LBBP

Pugazhendhi Vijayaraman

United States

5. How to simplify LBBP implant procedure

Ho-Chuen Yuen

Hong Kong SAR

1. Do we need to target the sweet spot, and how to do it?

Tachapong Ngarmukos

Thailand

2. Managing CRT benefit in atrial fibrillation patients

Suneet Mittal

United States

3. Device optimization strategies to improve CRT results after implantation

Niraj Varma

United States

4. Valve diseases in CRT patients after implantation: When to treat and which results?

Eric KY Chan

Hong Kong SAR

1. CRT in de-novo heart failure patients: When is the right time?

Mike Mangrum

United States

2. Therapy response after 20 years of clinical studies: Is the binary definition (responder/non-responder) still acceptable ?

Michael Gold

United States

3. Therapy response to conventional CRT in 2023: Are we still in the range of 60% ?

Seung-Jung Park

Korea

4. Multi point or multi-site in CRT: Which is better?

Christophe Leclercq

France

CRT Implantation #1: This is a great case story!

Chun-Chieh Wang

Taiwan

CRT Implantation #2: This is my worst case!

Sijing Cheng

China

CRT Implantation #3: Wow, I did it!

Christophe Leclercq

France

CRT Implantation #4: Never again!

Eric Lim

Singapore

1. Should CRT-P be our routine strategy instead of CRT-D

Devi Nair

United States

2. Response to CRT: Same benefits around the globe ?

Niraj Varma

United States

3. The future in CRT is through LBB-based pacing

Ronpichai Chokesuwattanaskul

Thailand

4. Multisensor-based management of heart failure patients

Katherine YY Fan

Hong Kong SAR

1. Patient preparation (Diagnosis, workup, intraoperative support)

Nigel Lever

New Zealand

2. Lead preparation (Lead construction, lead preparation, lead specific preparation)

Amitabh Yaduvanshi

India

3. Mechanical tools (Tightrail, evolution RL, tightrail C, shorty, polypropylene)

John Roshan Jacob

India

4. Laser and new offerings (Laser, tightrail guardian, xcardia)

Charles Love

United States

5. Femoral tools (Femoral as first vs rescue vs support)

Xuebin Li

China

1. Pocket and systemic CIED infections: Incidence, time course & consequences

Michael-Joseph Agbayani

Philippines

2. CIED hematomas: Incidence, prevention & consequences

Arisara Suwanagool

Thailand

3. Preventing CIED infections: What is under our control?

Haiying Li

China

4. Extraction for CIED infection: Comparison of treatments, timing, alternatives

Ryan Aleong

United States

5. Panel Discussion

Chairpersons:
Raymond Bayaua (Philippines), Masahiko Goya (Japan), Hoang Quang Minh (Vietnam)

1. Venous obstruction (e.g. Subclavian occlusion, SVC occlusion, Occluded vein-Failed lead-short implant duration)

Charles Love

United States

2. Extraction of leadless pacemakers

Devi Nair

United States

3. Trapped leads: brachiocephalic, SVC, Tricuspid

Ashish Nabar

India

4. Panel Discussion

12:00 - 13:00

Moderator: Daniel Chong (Singapore)

Session 1

• Optimized AF Workflow: Tips and Tricks in Utilizing Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ and EnSite™ Omnipolar Technology
• Q&A and Discussion
• Hands-On Demonstration

Eric Lim

Singapore

13:00 - 14:00

Moderator: Li-Wei Lo (Taiwan)

Session 2

• Optimized AF Workflow: Tips and Tricks in Utilizing Agilis™ NxT Steerable Introducer and TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™
• Q&A and Discussion
• Hands-On Demonstration

Nitish Badhwar

United States

14:00 - 15:00

Moderator:  Paul Lim (Singapore)

Session 3

• How to Optimize Patient Management Workflow with EnSite™ X EP System in AF Procedures?
• Q&A and Discussion
• Hands-On Demonstration

Han Ling

Australia

15:00 - 16:00

Session 4

• Lab Safety Management: Tips and Tricks in Utilizing ICE
• Q&A and Discussion
• Hands-On Demonstration

Sri Sundaram

United States

Moderators:
Jonathan Lipton (Australia), Boon Yew Tan (Singapore)

14:00-14:20

Tips and Tricks for Securing Stylet-Driven Active Fixation Lead Starting from Lead Design

Boon Yew Tan

Singapore

14:20-14:45

Electrogram Reading and Diagnosis

Jonathan Lipton

Australia

14:45-15:05

Understanding Right Bundle Branch Activation During LBBP

Boon Yew Tan

Singapore

15:05-15:15

New fixed curve catheter and helix locking tool overview

Paul Ryu

Korea

15:15-15:50

Tips & tricks for using new tools and case sharing (20 mins)
Hands-on practice (15 mins)

Jonathan Lipton
Boon Yew Tan

Australia
Singapore

15:50-16:15

Agilis HisPro™ Implant Hand-on by Abbott

Faculties & Abbott Specialists

Moderator:
Sunny Po (United States)

1. Welcome & Introduction
2. Differential diagnosis of wide-complex tachycardia by ECG
3. Case Study 1
4. Case Study 2
5. Closing

Sunny Po

United States

Chairpersons:
Jonathan Lipton (Australia), Seiji Takatsuki (Japan)

Connected Healthcare: How Remote Solutions, Are Advancing EP

Dale Yoo

United States

Question and Answer, Panel Discussion

All

Chairpersons:
Mina Chung (United States), Chu-Pak Lau (Hong Kong SAR), Swee-Chong Seow (Singapore), Pugazhendhi Vijayaraman (United States)

Welcome Remarks

Alan Cheng (Medtronic Leadership)

1. Perspective of CSP clinical practice

Weijian Huang

China

2. CSP Indications

Rajeev Pathak

Australia

3. 3830 Durability and Extraction

Pugazhendhi Vijayaraman

United States

4. Does LBB capture matters?

Xueying Chen

China

5. Lumenless leads or Stylet driven leads?

Shunmugasundaram Ponnusamy

India

6. A real life case sharing: Biventricular CRT or simply CSP?

Ling-Ling Ip

Hong Kong SAR

7. CSP case study

Matthew O‘Connor

New Zealand

Discussion

All

Moderators:
Ngai-Yin Chan (Hong Kong SAR), Andrea Natale (United States)

Opening

Andrea Natale

United States

1. ADVENT Data Readout

Edward Gerstenfeld

United States

2. PFA Clinical Studies

Oussama Wazni

United States

3. FARAPULSE Futures

Josef Kautzner

Czech Republic

4. POLARx FIT

Atsushi Kobori

Japan

Q&A / Discussion

All

Closing

Ngai-Yin Chan

Hong Kong SAR

Chairpersons:
Xia Sheng (China), Jaemin Shim (Korea)

ICE utilization in EP procedures (RFA, Cryo & PFA) to reduce fluoroscopy time and improve safety and efficacy

Chi-Keong Ching

Singapore

Question and Answer, Panel Discussion

All

Moderator:
Saravanan Krishinan (Malaysia)

Welcome Remarks

Saravanan Krishinan

Malaysia

1. Efficacy and efficient method of using Diamond Temp

Naoyuki Miwa

Japan

2. Patient Screening Experience, Cryoablation treated outcome comparison to AAD

Sirin Apiyasawat

Thailand

Panel Discussion

All

Closing Remarks

Saravanan Krishinan

Malaysia

Chairpersons:
Chin-Pang Chan (Hong Kong SAR), Chi-Keong Ching (Hong Kong SAR)

1. Case sharing of a stylet-driven lead CSP implant with novel catheter and helix locking tool

Hung-Fat Tse

Hong Kong SAR

2. Aveir Leadless Pacing Technology

Ivan Ho

United States

3. Aveir VR implantaion Case Sharing

Ikutaro Nakajima

Japan

4. Aveir VR implantaion Live Case-in-a-box

Ngai-Yin Chan

Hong Kong SAR

5. Aveir VR Retrieval Live Case-in-a-box

Sri Sundaram

United States

6. Mid-Range QRS and optimization for the Asian population

Niraj Varma

United States

Panelists:   Ngai-Yin Chan (Hong Kong SAR), Sri Sundaram (United States)

Chairpersons:
Haris Haqqani (Australia), Pipin Kojodjojo (Singapore)

AFib PVI from RF to PFA: Are We There Yet?

Sri Sundaram

United States

Question and Answer, Panel Discussion

Moderators:
Razali Omar (Malaysia), Wataru Shimizu (Japan)

Opening Remarks

Wataru Shimizu

Japan

1. Is Micra just an alternative therapy?

Arisara Suwanagool

Thailand

2. Best practices for a streamlined implant procedure

Balbir Singh

India

3 Micra VR2 & Micra AV2 – sharing next generation
- Micra VR2
- Micra AV2

Yuet-Wong Cheng
Oussama Wazni

Hong Kong SAR
United States

FAQ & Key Takeaways

Razali Omar

Malaysia

Chairperson:
Tsukasa Kamakura (Japan)

Welcome

Tsukasa Kamakura

Japan

1. ICD programming and importance of ATP (Clinical Aspect)

Martin Stiles

New Zealand

2. Reduced risk of Persistent/ Permanent AF with Bradycardia, improving quality of life for patients

Paul Condes Quetua

Philippines

3. Individualized ATP Strategy: How to reduce unnecessary shocks

Ki-Hong Lee

Korea

Panel Discussion

All

Closing Remarks: Summary and Session Feedback

Tsukasa Kamakura

Japan

Moderators:
Jonathan Kalman (Australia), Zulu Wang (China)

Opening

Zulu Wang

China

1. Optimized VT workflow and Strategy

Masato Fukunaga

Japan

     Round Table Discussion and Q&A

2. Improving efficiency with keeping safety using very high power short duration ablation for pulmonary vein isolation

So-Ryoung Lee

Korea

     Round Table Discussion and Q&A

Closing

Jonathan Kalman

Australia

Panelists: Hidehira Fukaya (Japan)

Chairpersons:
Minglong Chen (China), Takashi Kurita (Japan), Seiichiro Matsuo (Japan)

1. How could a novel flex tip contact force catheter influence my daily practice

Takanori Yamaguchi

Japan

2. How innovation in near-field signals provides new substrate insights while streamlining mapping interpretation in AF procedures

Dale Yoo

Korea

     Q&A Session

3. Early experience on Aveir VR Leadless implantation and retrieval

Chin-Pang Chan

Hong Kong SAR

4. US implanter experience on Aveir VR and Dr Leadless Technology

Devi Nair

United States

Chairperson:
Chu-Pak Lau (Hong Kong SAR)

1. How to apply recent guidelines on anticoagulation to complex elderly atrial fibrillation patients

Manuel Martinez Selles

Spain

2. The latest Korean real-world data on NOACs and dosing issues in Korea

Eue-Keun Choi

Korea

Moderators:
Godwin TC Leung (Hong Kong SAR)

A practical approach in Atrial Fibrillation Management

Hung-Fat Tse

Hong Kong SAR

Moderators:
Razali Omar (Malaysia)

Opening

Razali Omar

Malaysia

1. DiamondTemp clinical experience & ablation efficiency

Usman Siddiqui

United States

Panelist: Zulu Wang (China)

2. What we learned from PULSED AF

Atul Verma

Canada

Panelist: Cheng-Hung Chiang (Taiwan)

3. Clinical experience with the Affera™ Mapping and Ablation system and long-term outcome data

Andreas Metzner

Germany

Panelist: Daniel Chong (Singapore)

4. Affera™ Recorded Case Sharing

Andreas Metzner

Germany

Panelist: Joseph YS Chan (Hong Kong)

5. Optimizing the procedural workflow for AF Ablation using a zero exchange Transseptal approach

Matthew O'Connor

New Zealand

Panelist: Joseph YS Chan (Hong Kong SAR)

Closing

Razali Omar

Malaysia

Chairperson:
Leonard Ganz (United States)

1. My Aveir Leadless Experience and Key Learnings – Case 1

Derek Exner

Canada

     Discussion

2. My Aveir Leadless Experience and Key Learnings – Case 2

Rahul N. Doshi

United States

     Discussion

Moderator:
Andrea Natale (United States)

Opening

Andrea Natale

United States

1. Comprehensive management of AF – Role of WATCHMAN™ therapy in optimizing results

Andrea Natale

United States

Q&A

All

2. RECORD I data & China experience of ICE-guided practice & concomitant procedure

Zulu Wang

China

Q&A

All

3. Initial Singapore Experience: Combined PFA & LAAC

Jeremy Chow

Singapore

Q&A

All

4. WATCHMAN FLX™ recorded case

Ngai-Yin Chan

Hong Kong SAR

Q&A and Live Discussion

All

Moderator:
Suneet Mittal (United States)

Welcome

Suneet Mittal

United States

Patient Selection

Hariharan Sugumar

Australia

Panel: Early experience and learnings getting started

Jongmin Hwang

Korea

Panel Q&A

Suneet Mittal

United States

Moderator:
Ngai-Yin Chan (Hong Kong SAR)

Case Sharing:
Personalised DOAC use based on latest clinical trials and pharmacokinetic data

Gary CY Leung

Hong Kong SAR

Chairperson:
Takashi Kurita (Japan)

Opening Remarks

Stacey Churchwell (VP)

Welcome/Opening Remarks/Introduction

Takashi Kurita

Japan

LINQ II and AccuRhythm AI: Practical experience in Australia

Michael Wong

Australia

LINQ II and Artificial intelligence and the development of AccuRhythm AI: technical part

Ryan O’Leary

United States

Panel Discussion

Pipin Kojodjojo
Michael Wong
Ryan O’Leary
Abdul Raqib bin Abd Ghani

Singapore
Australia
United States
Malaysia

Closing Remarks

Takashi Kurita

Japan

Moderator: Man-Fai Ip

Heart-Kidney Crosstalk and the Role of SGLT2 Inhibition: From Cardiologist Perspective

Hung-Fat Tse

Hong Kong SAR

Heart-Kidney Crosstalk and the Role of SGLT2 Inhibition: From Nephrologist Perspective

Desmond Yap

Hong Kong SAR